arrow
N

Nicolas C. Issa

Brigham and Women's Hospital
H指数:24
被引数:2,214

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reactogenicity and Immunogenicity of RSV Vaccines in Immunocompromised Individuals With Hematological Malignancies

造血系统恶性肿瘤免疫受损个体中RSV疫苗的反应原性和免疫原性

2026-09-200
OAAI
Expression of HLA-B*35 is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-based Hematopoietic Cell Transplantation

HLA-B*35的表达与PTCy-based造血细胞移植后巨细胞病毒(CMV)病毒血症及临床显著CMV感染风险的增加相关。

2025-09-210
PRE
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy

B细胞耗竭患者中慢性SARS-CoV-2感染:免疫学及病毒学特征以及对联合和延长抗病毒治疗的反应

2025-09-014
PRE
Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study
2025-01-280
PRE
Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

HLA-B*35的表达与接受Ptcy为基础造血细胞移植的患者发生巨细胞病毒(CMV)病毒血症和临床显著CMV感染风险增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

早期巨细胞病毒(CMV)病毒载量负担可预测接受Ptcy为基础的造血细胞移植患者晚期临床显著CMV感染。

BLOOD
IF23.1
2024-11-050
PRE
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia
2024-01-252
OAAI
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients

嵌合抗原受体T细胞治疗受者的新型冠状病毒疫苗免疫原性

2023-06-0111
OAAI
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
2022-08-169
OAAI